PharmiWeb.com - Global Pharma News & Resources
16-Jul-2019

Nephrostomy Devices Market to Witness 7.6% CAGR by the end of 2026

The Global Nephrostomy Devices Market Size is anticipated to around USD 1.5 billion by 2026, this market is anticipated to grow with 7.6% CAGR during the forecast time period 2019 to 2026.

A greater awareness of the nephrostomy machines among doctors is driving the market, along with increasing instances of kidney stone illness. Another main factor in fuelling market growth is an increase in the incidence of ovarian, brown and prostate cancer and an improving healthcare infrastructure in developing countries.

The largest market share in North America is anticipated due to the increased incidence of kidney stone and ovarian, liver and prostate cancers. For example, in 2018, about 22,240 new cases of ovarian cancer were diagnosed in the USA, according to the American Cancer Society. In this industry, major businesses emphasize product launches and innovations in current products. Cook Medical, for example, launched the Universa and the two urinary drainage sets in February 2017.

The increasing popularity of percutaneous nephrostomy processes (PCN) is a main factor in the development of the worldwide nephrostomy device industry. Traditional open-label operations require a number of complications, leading to enhanced demand for minimally invasive operations such as PCN. PCN is a minimally invasive procedure for the treatment of obstruction in the upper urinary tract. This procedure is used for patients with kidney stones of more than 2 cm in size as first-line treatment. The incision is around 1 cm lower and leads to quicker regeneration and shorter hospitalizations.

Over the years, ovarian, kidney stone, bladder and prostate cancer have considerably improved incidence. As a consequence, in a number of nations, governments and private organisations, underline the benefits of nephrostomy systems, while minimizing the composition of therapy costs. Similarly different sellers focus on projects that raise awareness of nephrostomy instruments. The development of the nephrostomy device industry is anticipated to propel such projects during the predicted era.

Download Free Sample Report Pages for Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/1506

The increased incidence of kidney stone is the main driving factor in the worldwide market growth for nephrostomy products. In addition, the increased incidence of ovarian, bladder, prostate cancer, and other diseases are some of the prominent drivers of development in the market for nephrostomy instruments in patients who have been transplanted to kidney. Alternative processes such as ureteral stenting and percutaneous nephrostomy difficulties, however, are factors which hinder worldwide market development of nephrostomy instruments.

Key Findings

The segment guidewires resulted the world market in the nephrostomy industry in 2018 and is planned to grow further from 2019 to 2026 at the lowest CAGR.

The segment development is caused by increased instances of diseases of the kidney and urine and by less invasive guide wires.

2018 was dominated by the hospital segment. Percutaneous nephrostomy in most hospitals is conducted in comparison with emergency clinics, driving development in the segment.

The ASC segment is expected to record the largest CAGR because ASC's nephrostomy systems, such as important cost conservation and customized services, have been commonly used by ASC.

North America is the market leader because of a large number of targets, the accessibility of expert surgeons, a well-established health industry and the rapid use of sophisticated healthcare instruments.

Key Players amp; Strategies

Cardinal Health; Teleflex, Inc.; Becton, Argon Medical; Boston Scientific Corp.; Dickinson and Company; Cook Medical; Coloplast Group; B. Braun Melsungen AG; Olympus Corp.; and Uresil LLC are major firms in the market, with a greater focus on the new product development, technological progress and Mamp;A, to enhance their position on the worldwide market. Cook Medical, for example, started Universa together with two percutaneous urinary drainage sets in February 2017. The brand involves foley and ureteral catheters in various configurations and sizes to satisfy doctors and patients ' particular reference and needs.

View Detail Information at https://www.acumenresearchandconsulting.com/nephrostomy-devices-market

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Nephrostomy Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Nephrostomy Devices Market By Product
1.2.2.1. Global Nephrostomy Devices Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Nephrostomy Devices Market Revenue Share By Product in 2017
1.2.2.3. Nephrostomy Catheters
1.2.2.4. Guidewires
1.2.2.5. Sheath Dilators
1.2.2.6. Drainage Tubes
1.2.2.7. Others
1.2.3. Nephrostomy Devices Market By End Use
1.2.3.1. Global Nephrostomy Devices Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.3.2. Global Nephrostomy Devices Market Revenue Share By End Use in 2017
1.2.3.3. Emergency Clinics
1.2.3.4. Hospitals
1.2.3.5. Ambulatory Surgical Centers
1.2.4. Nephrostomy Devices Market by Geography
1.2.4.1. Global Nephrostomy Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Nephrostomy Devices Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Nephrostomy Devices Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Nephrostomy Devices Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Nephrostomy Devices Major Manufacturers in 2017

CHAPTER 4. NEPHROSTOMY DEVICES MARKET BY PRODUCT

4.1. Global Nephrostomy Devices Revenue By Product
4.2. Nephrostomy Catheters
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Guidewires
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Sheath Dilators
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Drainage Tubes
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NEPHROSTOMY DEVICES MARKET BY END USE

5.1. Global Nephrostomy Devices Revenue By End Use
5.2. Emergency Clinics
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hospitals
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Ambulatory Surgical Centers
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY

6.1. North America Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Nephrostomy Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Nephrostomy Devices Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE NEPHROSTOMY DEVICES MARKET BY COUNTRY

7.1. Europe Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Nephrostomy Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC NEPHROSTOMY DEVICES MARKET BY COUNTRY

8.1. Asia-Pacific Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Nephrostomy Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY

9.1. Latin America Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Nephrostomy Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST NEPHROSTOMY DEVICES MARKET BY COUNTRY

10.1. Middle East Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Nephrostomy Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA NEPHROSTOMY DEVICES MARKET BY COUNTRY

11.1. Africa Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Nephrostomy Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Cardinal Health
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Teleflex, Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Becton, Dickinson and Company
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Argon Medical
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Boston Scientific Corp.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Cook Medical
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Coloplast Group
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. B. Braun Melsungen AG
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Olympus Corp.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Uresil LLC
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Request for Customization at https://www.acumenresearchandconsulting.com/request-customization/1506

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1506

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 16-Jul-2019